Literature DB >> 30413645

Histamine H1 Receptor Contributes to Vestibular Compensation.

Zhang-Peng Chen1, Xiao-Yang Zhang1, Shi-Yu Peng1, Zhong-Qin Yang1, Yan-Bo Wang1, Yang-Xun Zhang1, Xi Chen1, Jian-Jun Wang2,3, Jing-Ning Zhu2,3.   

Abstract

Vestibular compensation is responsible for the spontaneous recovery of postural, locomotor, and oculomotor dysfunctions in patients with peripheral vestibular lesion or posterior circulation stroke. Mechanism investigation of vestibular compensation is of great importance in both facilitating recovery of vestibular function and understanding the postlesion functional plasticity in the adult CNS. Here, we report that postsynaptic histamine H1 receptor contributes greatly to facilitating vestibular compensation. The expression of H1 receptor is restrictedly increased in the ipsilesional rather than contralesional GABAergic projection neurons in the medial vestibular nucleus (MVN), one of the most important centers for vestibular compensation, in unilateral labyrinthectomized male rats. Furthermore, H1 receptor mediates an asymmetric excitation of the commissural GABAergic but not glutamatergic neurons in the ipsilesional MVN, which may help to rebalance bilateral vestibular systems and promote vestibular compensation. Selective blockage of H1 receptor in the MVN significantly retards the recovery of both static and dynamic vestibular symptoms following unilateral labyrinthectomy, and remarkably attenuates the facilitation of betahistine, whose effect has traditionally been attributed to its antagonistic action on the presynaptic H3 receptor, on vestibular compensation. These results reveal a previously unknown role for histamine H1 receptor in vestibular compensation and amelioration of vestibular motor deficits, as well as an involvement of H1 receptor in potential therapeutic effects of betahistine. The findings provide not only a new insight into the postlesion neuronal circuit plasticity and functional recovery in the CNS, but also a novel potential therapeutic target for vestibular disorders.SIGNIFICANCE STATEMENT Vestibular disorders manifest postural imbalance, nystagmus, and vertigo. Vestibular compensation is critical for facilitating recovery from vestibular disorders, and of great importance in understanding the postlesion functional plasticity in the adult CNS. Here, we show that postsynaptic H1 receptor in the medial vestibular nucleus (MVN) contributes greatly to the recovery of both static and dynamic symptoms following unilateral vestibular lesion. H1 receptor selectively mediates the asymmetric activation of commissural inhibitory system in the ipsilesional MVN and actively promotes vestibular compensation. The findings provide not only a new insight into the postlesion neuronal circuit plasticity and functional recovery of CNS, but also a novel potential therapeutic target for promoting vestibular compensation and ameliorating vestibular disorders.
Copyright © 2019 the authors 0270-6474/19/390420-14$15.00/0.

Entities:  

Keywords:  H1 receptor; commissural inhibitory system; medial vestibular nucleus; unilateral labyrinthectomy; vestibular compensation

Mesh:

Substances:

Year:  2018        PMID: 30413645      PMCID: PMC6335742          DOI: 10.1523/JNEUROSCI.1350-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

Review 1.  Intrinsic membrane properties of vertebrate vestibular neurons: function, development and plasticity.

Authors:  H Straka; N Vibert; P P Vidal; L E Moore; M B Dutia
Journal:  Prog Neurobiol       Date:  2005-11-02       Impact factor: 11.685

Review 2.  Histamine in the nervous system.

Authors:  Helmut L Haas; Olga A Sergeeva; Oliver Selbach
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Head impulse gain and saccade analysis in pontine-cerebellar stroke and vestibular neuritis.

Authors:  Luke Chen; Michael Todd; Gabor M Halmagyi; Swee Aw
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

4.  Medial cerebellar nucleus projects to feeding-related neurons in the ventromedial hypothalamic nucleus in rats.

Authors:  Bin Li; Qian-Xing Zhuang; He-Ren Gao; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Brain Struct Funct       Date:  2016-06-24       Impact factor: 3.270

5.  Medial vestibular nucleus in the guinea-pig: histaminergic receptors. II. An in vivo study.

Authors:  T Yabe; C de Waele; M Serafin; N Vibert; J M Arrang; M Mühlethaler; P P Vidal
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

Review 6.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

7.  Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat.

Authors:  Brahim Tighilet; Suzanne Trottier; Michel Lacour
Journal:  Eur J Pharmacol       Date:  2005-10-14       Impact factor: 4.432

8.  Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss.

Authors:  Christine Redon; Christophe Lopez; Laurence Bernard-Demanze; Michel Dumitrescu; Jacques Magnan; Michel Lacour; Liliane Borel
Journal:  J Clin Pharmacol       Date:  2010-10-12       Impact factor: 3.126

9.  Changes in the histaminergic system during vestibular compensation in the cat.

Authors:  Brahim Tighilet; Suzanne Trottier; Christiane Mourre; Michel Lacour
Journal:  J Physiol       Date:  2006-04-13       Impact factor: 5.182

10.  Histamine pharmacology: four years on.

Authors:  Paul L Chazot
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

View more
  6 in total

1.  Effect of the novel histamine H4 receptor antagonist SENS-111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss.

Authors:  Mathieu Petremann; Cindy Gueguen; Viviana Delgado Betancourt; Eric Wersinger; Jonas Dyhrfjeld-Johnsen
Journal:  Br J Pharmacol       Date:  2019-08-28       Impact factor: 8.739

Review 2.  Management of peripheral vertigo with antihistamines: New options on the horizon.

Authors:  Jonas Dyhrfjeld-Johnsen; Pierre Attali
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 3.  The Pharmacological Treatment of Pediatric Vertigo.

Authors:  Pasquale Viola; Gianmarco Marcianò; Alessandro Casarella; Davide Pisani; Alessia Astorina; Alfonso Scarpa; Elena Siccardi; Emanuele Basile; Giovambattista De Sarro; Luca Gallelli; Giuseppe Chiarella
Journal:  Children (Basel)       Date:  2022-04-20

4.  Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms.

Authors:  Fulvio Plescia; Pietro Salvago; Francesco Dispenza; Giuseppe Messina; Emanuele Cannizzaro; Francesco Martines
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

5.  Effects of Betahistine on the Development of Vestibular Compensation after Unilateral Labyrinthectomy in Rats.

Authors:  Junya Fukuda; Kazunori Matsuda; Go Sato; Tadashi Kitahara; Momoyo Matsuoka; Takahiro Azuma; Yoshiaki Kitamura; Koichi Tomita; Noriaki Takeda
Journal:  Brain Sci       Date:  2021-03-11

Review 6.  Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

Authors:  Giulio Di Mizio; Gianmarco Marcianò; Caterina Palleria; Lucia Muraca; Vincenzo Rania; Roberta Roberti; Giuseppe Spaziano; Amalia Piscopo; Valeria Ciconte; Nunzio Di Nunno; Massimiliano Esposito; Pasquale Viola; Davide Pisani; Giovambattista De Sarro; Milena Raffi; Alessandro Piras; Giuseppe Chiarella; Luca Gallelli
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.